AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AstraZeneca PLC
Total Equity Peer Comparison

Comparables:
GSK
INDV
HIK
DPH
A
APH

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Total Equity
$39.5B
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
6%
GlaxoSmithKline PLC
LSE:GSK
Total Equity
ÂŁ14.4B
CAGR 3-Years
-2%
CAGR 5-Years
32%
CAGR 10-Years
9%
Indivior PLC
LSE:INDV
Total Equity
-$121m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Equity
$2.3B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
7%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Equity
ÂŁ755.2m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
16%
A
Alliance Pharma PLC
LSE:APH
Total Equity
ÂŁ222.9m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
13%

See Also

What is AstraZeneca PLC's Total Equity?
Total Equity
39.5B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Total Equity amounts to 39.5B USD.

What is AstraZeneca PLC's Total Equity growth rate?
Total Equity CAGR 10Y
6%

Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for AstraZeneca PLC have been 36% over the past three years , 24% over the past five years , and 6% over the past ten years .

Back to Top